Remission: Today’s Target in the Treatment of Mood and Anxiety Disorders
By Charles B. Nemeroff, MD, PhD
New Developments in Depression and Anxiety Disorders
Advancing the Treatment of Mood and Anxiety Disorders: The First 10 Years’ Experience with Paroxetine
Neuropharmacology of Paroxetine
By Michael J. Owens, PhD, and Charles B. Nemeroff, MD, PhD
Pharmacology of Valproate
Advancing the Treatment of Anxiety Disorders: New Findings and Novel Uses for Atypical Antipsychotics
Early-Life Adversity, CRF Dysregulation, and Vulnerability to Mood and Anxiety Disorders
Drug Development for Anxiety Disorders: New Roles for Atypical Antipsychotics
By William H. Carson, MD, Hisashi Kitagawa, PhD, and Charles B. Nemeroff, MD, PhD
La guía 2016 sobre interacciones entre medicamentos psicotrópicos
Dr. C. Lindsay DeVane y Dr. Charles B. Nemeroff
EDITOR’S LETTER
Charles B. Nemeroff, MD, PhD
La guía 2016 sobre interacciones entre medicamentos psicotrópicos, Part 2
C. Lindsay DeVane, PharmD y Charles B. Nemeroff, MD, PhD